All News

The Wellcome Trust is reaching outside the UK to fund translational research and derisk projects for future investors.

ACES winner Kee Square was spun out of the Politecnico di Milano with commercial ambitions for software that can help security services find their suspect.

The prospect of a sub-$1,000 human genome sequence moved closer as Oxford Nanopore Technologies Ltd agreed a marketing deal with Illumina Inc for its low-cost sequencing technology.

A pan-European project to develop standards for the collection of samples for use in diagnostics has been launched as part of Framework Programme 7. The project aims to increase accuracy and safety, and to create a single market for diagnostics products.